- AU$217.65m
- AU$200.61m
- NZ$103.85m
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 08:31:31
Australia Stock Exchange release from AROA BIOSURGERY : September Quarterly Report and Appendix 4C
Australia Stock Exchange release from AROA BIOSURGERY : Notification of Quarterly Webinar
Brief: Aroa Biosurgery Says H1 Product Sales Revenue Was About NZ$17 Mln, Grew 108%
ASX-listed Aroa Biosurgery jumps on strong HY sales, forecast hike
Australia Stock Exchange release from AROA BIOSURGERY : Aroa delivers strong half, Myriad GPO win
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 08:31:51
Australia Stock Exchange release from AROA BIOSURGERY : Ceasing to be a substantial holder
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Section 708A Notice
Australia Stock Exchange release from AROA BIOSURGERY : Allotment of Share Purchase Plan Shares
Australia Stock Exchange release from AROA BIOSURGERY : Share Purchase Plan Offer Closes
Australia Stock Exchange release from AROA BIOSURGERY : Change of Director's Interest Notice - JM
Australia Stock Exchange release from AROA BIOSURGERY : Notification regarding unquoted securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Section 708A Notice
Australia Stock Exchange release from AROA BIOSURGERY : Substantial Holders Notification
Australia Stock Exchange release from AROA BIOSURGERY : Change of Director's Interest Notice - PM
Australia Stock Exchange release from AROA BIOSURGERY : New real-world data shows Endoform improves wound closure